TrialCritical care (London, England)2017

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.

Eleni Palli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.